Evidence map›Paper›PMID 24972151›Full record

ArticleBlood cancer journal2014

JAK2V617F mRNA metabolism in myeloproliferative neoplasm cell lines.

P Nauroy, F Delhommeau, F Baklouti

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

P NauroymRNA Metabolism in Normal and Pathological Cells, CNRS UMR 5534, Université Lyon 1, Villeurbanne, France.
F Delhommeau1] Sorbonne Universités, UPMC Univ Paris 06, GRC no. 07, Groupe de Recherche Clinique sur les Myéloproliférations Aiguës et Chroniques MyPAC, Paris, France [2] AP-HP, Hôpital Saint-Antoine, Laboratoire d'Hématologie, Paris, France [3] Sorbonne Universités, UPMC Univ Paris 06, UMR_S 938, CDR Saint-Antoine, Paris, France [4] INSERM, UMR_S 938, CDR Saint-Antoine, Paris, France.
F BakloutimRNA Metabolism in Normal and Pathological Cells, CNRS UMR 5534, Université Lyon 1, Villeurbanne, France.
Centre National de la Recherche Scientifique · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell Line, TumorHaplotypesHumansJanus Kinase 2MutationMyeloproliferative DisordersRNA, MessengerRNA SplicingJAK2 protein, humanJanus Kinase 2RNA, Messenger

Identifiers

PMID24972151
PMCPMC4080214
OpenAlexW2139049237

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.